Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer

NCT03015740 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Clear Cell Renal Cell Carcinoma
Metastatic Kidney Carcinoma
Stage III Renal Cell Cancer AJCC v7
Stage IV Renal Cell Cancer AJCC v7

Interventions

OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Nivolumab
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
DRUG: Sitravatinib

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]